Robin Carlton pays about $650 a month for a plan on the Missouri health insurance exchange that covers him and his two teenage kids. That monthly total is $200 higher than what he paid last year, due in part to the expiration in December of covid pandemic-era premium tax credits. But the self-employed St. Louis…
At DiMe’s Healthcare 2030 Summit, four healthcare leaders shared the innovations they believe could most improve care, from AI-driven solutions to reduce medical errors to stronger primary care relationships that could save billions. The post 4 Execs’ Wishes for a Better Healthcare Future appeared first on MedCity News.
Shalin Shah, CEO of Marius Pharmaceuticals, which makes an oral testosterone replacement drug, thinks TRT therapy should no longer be regulated as a controlled substance The post MedCity Pivot Podcast: Should Testosterone Replacement Therapy Be Less Regulated? appeared first on MedCity News.
A multiple myeloma cell therapy has encouraging results analysts say could make it best in its class and a gene-editing therapy is showing early promise in sickle cell disease. Here’s a recap of those developments and others from the annual meeting of the American Society of Clinical Oncology. The post ASH 2024 Recap: Movement in…
This volume addresses rising distrust in food safety, shifts in social media content moderation, and the trend of self-diagnosis and treatment based on social media videos.
AI transforms incident data with the ability to analyze large volumes of reports, surface patterns and highlight problem areas. These insights allow hospital leaders to not only identify trends but also anticipate risks and take more targeted steps to improve patient safety. The post Checking The Blind Spots: How AI-Driven Safety Reporting Can Make The…
The autism care system in the U.S. needs stronger accountability and transparency. But it also needs new models that can deliver higher-quality care to more families, more efficiently, and regardless of where they live. The post Autism Therapy is in Dire Need of a New Business Model appeared first on MedCity News.
Cuando los subsidios federales mejorados expiraron a fines de 2025, muchas personas que compraban su propio seguro de salud en los mercados estatales y federales vieron aumentar sus primas mensuales. Para reducir costos, muchos cambiaron a planes de salud con deducibles altos. Estos planes ofrecen pagos mensuales más bajos, pero los pacientes pueden enfrentar gastos…
This brief provides an overview of current lawsuits in health policy including preventive services, abortion care, gender affirming care, Medicare drug price negotiations, nursing home staffing rules, private coverage consumer protections, and protections and health coverage for Deferred Action for Childhood Arrivals (DACA) recipients; how they may be affected by the incoming Trump administration; and…
This policy watch examines the implications of new proposed regulations that would allow Medicare and require Medicaid to cover drugs used to treat obesity, including a relatively new class of highly effective but costly drugs known as GLP-1s.